Home » MORPHOSYS AND CHIMERA ANNOUNCE COOPERATION AND CO-MARKETING
MORPHOSYS AND CHIMERA ANNOUNCE COOPERATION AND CO-MARKETING
Antibodies by Design, a Division of MorphoSys AG, Munich, and Chimera Biotec GmbH
have announced the start of a co-marketing agreement between the two companies.
Within the scope of the agreement the parties agree to co-market generation of
monoclonal antibodies by Antibodies by Design and Chimera Biotec's complementary
Imperacer assay technology for ultra-sensitive antigen detection.
Genomics
and Proteomics
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May